SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001579
Filing Date
2024-01-18
Accepted
2024-01-18 08:35:16
Documents
13
Period of Report
2024-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240117_8k.htm   iXBRL 8-K 25800
  Complete submission text file 0001437749-24-001579.txt   157563

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240112.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240112_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240112_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240112_pre.xml EX-101.PRE 11584
7 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240117_8k_htm.xml XML 2552
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 24540173
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)